Yemen gets $14.8million pledge to fight AIDS:
This article was originally published in Clinica
The Yemen has been awarded $5.5m by the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, to tackle HIV/AIDS over the next two years. A further $9.3m have been earmarked for disbursement over the following three years. Last year, the Global Fund granted the Yemen some $12m to support the national programme to fight malaria.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.